Once-daily extended-release niacin lowers serum phosphorus concentrations in patients with metabolic syndrome dyslipidemia.
Hu
Susie
S
Shearer
Gregory C
GC
Steffes
Michael W
MW
Harris
William S
WS
Bostom
Andrew G
AG
D002118:Calcium / Q000097:blood; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D005919:Glomerular Filtration Rate; D006801:Humans; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D024821:Metabolic Syndrome / Q000097:blood* / Q000503:physiopathology; D009525:Niacin / Q000008:administration & dosage*; D010758:Phosphorus / Q000097:blood*; D012709:Serum Albumin / Q000032:analysis
D003692:Delayed-Action Preparations; D000960:Hypolipidemic Agents; D012709:Serum Albumin; D009525:Niacin; D010758:Phosphorus; D002118:Calcium